|
⚲
|
| Keyboard |
| Sing George L
✚
|
|
|---|---|
| CIK # | 0001225471 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001225471] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Regeneron Pharmaceuticals Inc | |
| Sing George L |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2026-01-02 | Grant | 155 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 1,962 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2025-12-30 | Tax withheld | 6,188 | $774.03 | 4,789,698 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2025-12-30 | Option exercise | 9,212 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2025-12-30 | Option exercise | 9,212 | $520.01 | 4,790,332 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2025-01-02 | Grant | 166 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 1,958 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-12-31 | Tax withheld | 1,948 | $708.19 | 1,379,554 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-12-31 | Option exercise | 3,338 | $413.33 | 1,379,696 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-12-31 | Option exercise | 3,338 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-09-04 | Gift | 1,200 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-05-03 | Tax withheld | 877 | $942.53 | 826,599 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-05-03 | Option exercise | 2,000 | $413.33 | 826,660 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-05-03 | Option exercise | 2,000 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-02-26 | Option exercise | 1,000 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-02-26 | Sell | 500 | $995.00 | 497,500 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-02-26 | Sell | 500 | $990.00 | 495,000 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-02-26 | Option exercise | 500 | $413.33 | 206,665 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-02-26 | Option exercise | 500 | $413.33 | 206,665 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-02-23 | Option exercise | 500 | $413.33 | 206,665 |
| showing 20 of 200 most recent transactions | |||||